KRAS and colorectal carcinoma: The overexpression of oncogenic K-Ras is linked to the upregulation of Ephexin1 [21, 22], and its expression levels increase in association with the progression of lung cancer (LC), colorectal (CRC), and thyroid cancers [22–24].